T1	Participants 59 77	healthy volunteers
T2	Participants 246 254	migraine
T3	Participants 425 442	Twenty volunteers
T4	Participants 590 643	Sixteen volunteers completed the two treatment phases
T5	Participants 1165 1239	patients treated concurrently with selective serotonin reuptake inhibitors
